Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQ-A3334 in treatment-naive and virologically suppressed chronic hepatitis B
CTR20192308Phase 2Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tq-a3334 in Chronic Hepatitis B (CHB), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Nov 2019; status: completed.
02
Drugs
tq-a3334
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20192308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192308.